developed a risk score model based on DNA methylation‐expressed (DME) gene profiles from 259 glioma samples (WHO grades I–III, TCGA database) and identified six DME genes (EMP3, DDIT4L, MEOX2, OCIAD2, TGFB2, TNFRSF12A) associated with survival outcomes [51]. This evidence concerns the gene TGFB2 and glioma.